Future Medicine: Biomarkers in Medicine This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Low expression of < em > GOT2 < /em > promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma
Conclusion: GOT2 plays a tumor-inhibitory role in HCC and may be a potential therapeutic target for HCC.PMID:38095985 | DOI:10.2217/bmm-2023-0236 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Qiuli Liang Shun Liu Fuqiang Yin Meiliang Liu Lijun Wang Erna Guo Lei Lei Liuyu Wu Yu Yang Di Zhang Xiaoyun Zeng Source Type: research
The emerging role of miR-320a in lung cancer: a comprehensive review
Biomark Med. 2023 Dec 14. doi: 10.2217/bmm-2023-0215. Online ahead of print.ABSTRACTA specialized biomarker(s) for lung cancer is imperative owing to its high mortality. Continuing our earlier work demonstrating the role of miR-320a as a tumor suppressor, here we discuss the most recent updates on miR-320a in lung cancer pathogenesis. We found that miR-320a modulates levels of diverse cancer-associated molecules and signaling pathways, and is also involved in modulating the immune microenvironment of lung cancer during its pathogenesis. We also discuss how miR-320a encapsulated in exosomes inhibits invasive phenotypes of l...
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Adrija Mohanta Rajiv R Kumar Rahul K Singh Surojit Mandal Ritu Yadav Rinku Khatkar Uttam Sharma Vivek Uttam Manjit K Rana Amrit Ps Rana Aklank Jain Source Type: research
Diagnostic value of serum autotaxin level in colorectal cancer
Conclusion: The serum ATX level is a useful biomarker for CRC.PMID:38095984 | DOI:10.2217/bmm-2023-0496 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Abdurrahman Ba şpınar Didem Özkan Serhat Tokg öz Alper Bilal Özkardeş İsmail Oskay Kaya Source Type: research
Low expression of < em > GOT2 < /em > promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma
Conclusion: GOT2 plays a tumor-inhibitory role in HCC and may be a potential therapeutic target for HCC.PMID:38095985 | DOI:10.2217/bmm-2023-0236 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Qiuli Liang Shun Liu Fuqiang Yin Meiliang Liu Lijun Wang Erna Guo Lei Lei Liuyu Wu Yu Yang Di Zhang Xiaoyun Zeng Source Type: research
The emerging role of miR-320a in lung cancer: a comprehensive review
Biomark Med. 2023 Dec 14. doi: 10.2217/bmm-2023-0215. Online ahead of print.ABSTRACTA specialized biomarker(s) for lung cancer is imperative owing to its high mortality. Continuing our earlier work demonstrating the role of miR-320a as a tumor suppressor, here we discuss the most recent updates on miR-320a in lung cancer pathogenesis. We found that miR-320a modulates levels of diverse cancer-associated molecules and signaling pathways, and is also involved in modulating the immune microenvironment of lung cancer during its pathogenesis. We also discuss how miR-320a encapsulated in exosomes inhibits invasive phenotypes of l...
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Adrija Mohanta Rajiv R Kumar Rahul K Singh Surojit Mandal Ritu Yadav Rinku Khatkar Uttam Sharma Vivek Uttam Manjit K Rana Amrit Ps Rana Aklank Jain Source Type: research
Diagnostic value of serum autotaxin level in colorectal cancer
Conclusion: The serum ATX level is a useful biomarker for CRC.PMID:38095984 | DOI:10.2217/bmm-2023-0496 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Abdurrahman Ba şpınar Didem Özkan Serhat Tokg öz Alper Bilal Özkardeş İsmail Oskay Kaya Source Type: research
Low expression of < em > GOT2 < /em > promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma
Conclusion: GOT2 plays a tumor-inhibitory role in HCC and may be a potential therapeutic target for HCC.PMID:38095985 | DOI:10.2217/bmm-2023-0236 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Qiuli Liang Shun Liu Fuqiang Yin Meiliang Liu Lijun Wang Erna Guo Lei Lei Liuyu Wu Yu Yang Di Zhang Xiaoyun Zeng Source Type: research
The emerging role of miR-320a in lung cancer: a comprehensive review
Biomark Med. 2023 Dec 14. doi: 10.2217/bmm-2023-0215. Online ahead of print.ABSTRACTA specialized biomarker(s) for lung cancer is imperative owing to its high mortality. Continuing our earlier work demonstrating the role of miR-320a as a tumor suppressor, here we discuss the most recent updates on miR-320a in lung cancer pathogenesis. We found that miR-320a modulates levels of diverse cancer-associated molecules and signaling pathways, and is also involved in modulating the immune microenvironment of lung cancer during its pathogenesis. We also discuss how miR-320a encapsulated in exosomes inhibits invasive phenotypes of l...
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Adrija Mohanta Rajiv R Kumar Rahul K Singh Surojit Mandal Ritu Yadav Rinku Khatkar Uttam Sharma Vivek Uttam Manjit K Rana Amrit Ps Rana Aklank Jain Source Type: research
Diagnostic value of serum autotaxin level in colorectal cancer
Conclusion: The serum ATX level is a useful biomarker for CRC.PMID:38095984 | DOI:10.2217/bmm-2023-0496 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Abdurrahman Ba şpınar Didem Özkan Serhat Tokg öz Alper Bilal Özkardeş İsmail Oskay Kaya Source Type: research
Low expression of < em > GOT2 < /em > promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma
Conclusion: GOT2 plays a tumor-inhibitory role in HCC and may be a potential therapeutic target for HCC.PMID:38095985 | DOI:10.2217/bmm-2023-0236 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Qiuli Liang Shun Liu Fuqiang Yin Meiliang Liu Lijun Wang Erna Guo Lei Lei Liuyu Wu Yu Yang Di Zhang Xiaoyun Zeng Source Type: research
The emerging role of miR-320a in lung cancer: a comprehensive review
Biomark Med. 2023 Dec 14. doi: 10.2217/bmm-2023-0215. Online ahead of print.ABSTRACTA specialized biomarker(s) for lung cancer is imperative owing to its high mortality. Continuing our earlier work demonstrating the role of miR-320a as a tumor suppressor, here we discuss the most recent updates on miR-320a in lung cancer pathogenesis. We found that miR-320a modulates levels of diverse cancer-associated molecules and signaling pathways, and is also involved in modulating the immune microenvironment of lung cancer during its pathogenesis. We also discuss how miR-320a encapsulated in exosomes inhibits invasive phenotypes of l...
Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Adrija Mohanta Rajiv R Kumar Rahul K Singh Surojit Mandal Ritu Yadav Rinku Khatkar Uttam Sharma Vivek Uttam Manjit K Rana Amrit Ps Rana Aklank Jain Source Type: research
Prognostic value of the Lung Immune Prognostic Index for HER-2-negative metastatic gastric cancer
Conclusion: Good LIPI correlated with better outcomes for patients with MGC in the anti-PD-1-treated group but not in the chemotherapy-treated group.PMID:38085163 | DOI:10.2217/bmm-2023-0052 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 12, 2023 Category: Internal Medicine Authors: Miaomiao Gou Yong Zhang Tongtong Qu Ru Jia Zhikuan Wang Guanghai Dai Source Type: research
Neutrophil-to-serum iron ratio as a promising inflammatory biomarker for acute myocardial infarction and Gensini score
Conclusion: N/SI was discovered to be a new and effective inflammatory biomarker for AMI and Gensini score.PMID:38085167 | DOI:10.2217/bmm-2023-0177 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 12, 2023 Category: Internal Medicine Authors: Jiedong Ma Xiaojin Liu Hongqi Zhang Yufei Chen Jiamin Tian Wei Shen Source Type: research
Prognostic value of the Lung Immune Prognostic Index for HER-2-negative metastatic gastric cancer
Conclusion: Good LIPI correlated with better outcomes for patients with MGC in the anti-PD-1-treated group but not in the chemotherapy-treated group.PMID:38085163 | DOI:10.2217/bmm-2023-0052 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 12, 2023 Category: Internal Medicine Authors: Miaomiao Gou Yong Zhang Tongtong Qu Ru Jia Zhikuan Wang Guanghai Dai Source Type: research
Neutrophil-to-serum iron ratio as a promising inflammatory biomarker for acute myocardial infarction and Gensini score
Conclusion: N/SI was discovered to be a new and effective inflammatory biomarker for AMI and Gensini score.PMID:38085167 | DOI:10.2217/bmm-2023-0177 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - December 12, 2023 Category: Internal Medicine Authors: Jiedong Ma Xiaojin Liu Hongqi Zhang Yufei Chen Jiamin Tian Wei Shen Source Type: research